Horace Roman1, Clotilde Hennetier2, Basma Darwish2, Alexandra Badescu3, Marie Csanyi4, Moutaz Aziz4, Jean-Jacques Tuech5, Carole Abo2. 1. Department of Gynecology and Obstetrics, Rouen University Hospital, Rouen, France; Research Group 4308, Spermatogenesis and Gamete Quality, IHU Rouen Normandy, IFRMP23, Reproductive Biology Laboratory, Rouen University Hospital, Rouen, France. Electronic address: horace.roman@gmail.com. 2. Department of Gynecology and Obstetrics, Rouen University Hospital, Rouen, France. 3. Department of Gynecology and Obstetrics, Rouen University Hospital, Rouen, France; University of Medicine and Pharmacy of Targu Mures, Targu Mures, Romania. 4. Department of Pathology, Rouen University Hospital, Rouen, France. 5. Department of Surgery, Rouen University Hospital, Rouen, France.
Abstract
OBJECTIVE: To evaluate the impact of bowel occult microscopic endometriosis (BOME) implants on postoperative outcomes in patients treated with colorectal resection for deep infiltrating digestive endometriosis. DESIGN: Prospective series of consecutive patients with deep colorectal endometriosis managed by colorectal resection in our department from June 2009 to November 2014 and enrolled in the CIRENDO database (NCT02294825). SETTING: University tertiary referral center. PATIENT(S): One hundred three patients managed by colorectal resection for deep infiltrating endometriosis. INTERVENTION(S): Histologic examination of colorectal resection specimens. MAIN OUTCOME MEASURE(S): Patient characteristics, preoperative and 1-year postoperative symptoms and intraoperative findings were compared between women with and without BOME on specimen resection margins. RESULT(S): In 15 cases, BOME was found in one (nine cases) or both resection limits (six cases). No statistical significance was found between BOME and height of colorectal anastomosis, length of the resected bowel specimen or depth of rectal wall infiltration. One patient with BOME underwent a second colorectal resection 5 years later for rectal recurrence. Comparison between the rates of dyschezia, diarrhea, constipation, bloating and overall values of GIQLI and KESS scores 1 and 3 years postoperatively showed no statistical significance between women with and without BOME. CONCLUSION(S): BOME was found in 14.6% of specimen resection margins. No impact on either pelvic or digestive symptoms was observed after 1-year follow-up postoperatively. CLINICAL TRIAL REGISTRATION NUMBER: NCT02294825.
OBJECTIVE: To evaluate the impact of bowel occult microscopic endometriosis (BOME) implants on postoperative outcomes in patients treated with colorectal resection for deep infiltrating digestive endometriosis. DESIGN: Prospective series of consecutive patients with deep colorectal endometriosis managed by colorectal resection in our department from June 2009 to November 2014 and enrolled in the CIRENDO database (NCT02294825). SETTING: University tertiary referral center. PATIENT(S): One hundred three patients managed by colorectal resection for deep infiltrating endometriosis. INTERVENTION(S): Histologic examination of colorectal resection specimens. MAIN OUTCOME MEASURE(S): Patient characteristics, preoperative and 1-year postoperative symptoms and intraoperative findings were compared between women with and without BOME on specimen resection margins. RESULT(S): In 15 cases, BOME was found in one (nine cases) or both resection limits (six cases). No statistical significance was found between BOME and height of colorectal anastomosis, length of the resected bowel specimen or depth of rectal wall infiltration. One patient with BOME underwent a second colorectal resection 5 years later for rectal recurrence. Comparison between the rates of dyschezia, diarrhea, constipation, bloating and overall values of GIQLI and KESS scores 1 and 3 years postoperatively showed no statistical significance between women with and without BOME. CONCLUSION(S): BOME was found in 14.6% of specimen resection margins. No impact on either pelvic or digestive symptoms was observed after 1-year follow-up postoperatively. CLINICAL TRIAL REGISTRATION NUMBER: NCT02294825.
Authors: Andrea Balla; Silvia Quaresima; José D Subiela; Mostafa Shalaby; Giuseppe Petrella; Pierpaolo Sileri Journal: Int J Colorectal Dis Date: 2018-05-10 Impact factor: 2.571
Authors: H Roman; B Merlot; D Forestier; M Noailles; E Magne; T Carteret; J-T Tuech; D C Martin Journal: Hum Reprod Date: 2021-02-18 Impact factor: 6.918
Authors: Peter Tschann; Nikola Vitlarov; Martin Hufschmidt; Daniel Lechner; Paolo N C Girotti; Felix Offner; Burghard Abendstein; Ingmar Königsrainer Journal: Eur J Med Res Date: 2021-01-23 Impact factor: 2.175
Authors: Antonio Simone Laganà; Simone Garzon; Martin Götte; Paola Viganò; Massimo Franchi; Fabio Ghezzi; Dan C Martin Journal: Int J Mol Sci Date: 2019-11-10 Impact factor: 5.923